Trademark: 90309462
Word
DIFFDX-MELANOMA
Status
Registered
Status Code
700
Status Date
Tuesday, December 28, 2021
Serial Number
90309462
Registration Number
6604225
Registration Date
Tuesday, December 28, 2021
Mark Type
4000
Filing Date
Tuesday, November 10, 2020

Trademark Owner History
Castle Biosciences Incorporated - Original Registrant

Classifications
44 Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression

Trademark Events
Sep 13, 2022
Teas Change Of Correspondence Received
Sep 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 28, 2021
Registered-Supplemental Register
Nov 19, 2021
Law Office Publication Review Completed
Nov 18, 2021
Assigned To Lie
Nov 18, 2021
Approved For Registration Supplemental Register
Oct 18, 2021
Teas/Email Correspondence Entered
Oct 18, 2021
Correspondence Received In Law Office
Oct 18, 2021
Teas Response To Office Action Received
Apr 20, 2021
Notification Of Non-Final Action E-Mailed
Apr 20, 2021
Non-Final Action E-Mailed
Apr 20, 2021
Non-Final Action Written
Apr 19, 2021
Assigned To Examiner
Jan 9, 2021
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24